Distributing Vaccine Fairly During Influenza Pandemics – A Case Study from Berlin

Chapter
Part of the Public Health Ethics Analysis book series (PHES, volume 1)

Abstract

At the beginning of an influenza pandemic, scarcity of vaccine is unavoidable. This raises questions about fair distribution and prioritisation of particular groups. During the H1N1 pandemic in 2009 and 2010, the prioritisation of patient groups for the vaccination against influenza raised a series of ethical concerns. These related to the problems of uncertainty about outcomes at the onset of a pandemic, the difficulty of defining a clear goal of vaccination campaigns, and the practical problems brought about by the intense challenges that health care systems are faced with in a pandemic. In this paper, Berlin is used as a case study to show that at least some of these problems are related to a failure to integrate pandemic policy between different organisational levels. This failure proved problematic in two instances, first where policies overlapped and contradicted each other, and second where the minutiae of vaccine provision created problems for more abstract assumptions about fair allocation of scarce resources. It will be shown that some aspects of these problems may be remediable by applying principles of procedural justice. However, in order to properly integrate the micro and the macro scale, bioethicists will have to work alongside those with clinical expertise, and deploy models of thinking both from conventional doctor-patient bioethics and more population-level public health ethics.

Keywords

Health Care Worker Procedural Justice Distributive Justice Influenza Pandemic Vaccination Campaign 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Arras, J.D. 2005. Rationing vaccine during an avian influenza pandemic: Why it won’t be easy. Yale Journal of Biology and Medicine 78: 283–296.Google Scholar
  2. Barry, J. 2009. The great influenza: The story of the deadliest pandemic in history. New York: Penguin.Google Scholar
  3. Battin, M.P., L.P. Francis, J.A. Jacobson, and C.B. Smith. 2009. The patient as victim and vector: Ethics and infectious disease. New York: Oxford University Press.CrossRefGoogle Scholar
  4. Brock, D.W. 1987. Truth or consequences: The role of philosophers in policy-making. Ethics 97(4): 786–791.CrossRefGoogle Scholar
  5. Bryson, C., and B. New. 2000. Health care rationing – A cut too far? In British social attitudes: The 17th report, ed. R. Jowell, J. Curtice, A. Park, et al., 42 ff. London: Sage.Google Scholar
  6. Buda, S., H. Wilking, B. Schweiger, U. Buchholz, K. Köpke, and W. Haas. 2010. Influenza-­Wochenbericht KW 9, vol. 9. Berlin: Robert-Koch-Institut.Google Scholar
  7. Joint Committee on Vaccination and Immunisation. 2010. Protocol for the work of the JCVI and a Code of Practice for JCVI members and members of its Sub-committees. Available at http://www.dh.gov.uk/health/about-us/public-bodies-2/advisory-bodies/jcvi/.
  8. Coleman, C., and A. Reis. 2007. Ethical considerations in developing a public health response to pandemic influenza. Geneva: World Health Organization.Google Scholar
  9. Cribb, A. 2010. Translational ethics? The theory–practice gap in medical ethics. Journal of Medical Ethics 36(4): 207–210. doi:10.1136/jme.2009.029785.CrossRefGoogle Scholar
  10. Daniels, N. 2009. Just health: Meeting health needs fairly. Cambridge: Cambridge University Press.Google Scholar
  11. Daniels, N., and J. Sabin. 1997. Limits to health care: Fair procedures, democratic deliberation, and the legitimacy problem for insurers. Philosophy & Public Affairs 26(4): 303–350.CrossRefGoogle Scholar
  12. Goldman, A. 2001. Experts: Which ones should you trust? Philosophy and Phenomenological Research LXIII(1): 85–110.CrossRefGoogle Scholar
  13. Hine, D. 2010. The 2009 Influenza Pandemic – an independent review of the UK response to the 2009 influenza pandemic. Trans. P.F.R.R. Team. Cabinet Office.Google Scholar
  14. Kass, N.E., J. Otto, D. O’Brien, and M. Minson. 2008. Ethics and severe pandemic influenza: Maintaining essential functions through a fair and considered response [Review]. Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science 6(3): 227–236. doi: 10.1089/bsp. 2008.0020.CrossRefGoogle Scholar
  15. Kaufmann, S. 2007. The new plagues: Pandemics and poverty in a globalized world. Trans. C. M, The Sustainability Project. Frankfurt a.M.: Haus Publishing.Google Scholar
  16. Kotalik, J. 2010. Examining the principle of subsidiarity for bioethics. Kennedy Institute of Ethics Journal 20(4): 371–390.Google Scholar
  17. Krause, G., A. Gilsdorf, J. Becker, K. Bradt, C. Dreweck, B. Gartner, et al. 2010. First exchange of experiences concerning the H1N1 pandemic in Germany 2009/2010: Report on a workshop held March 22–23, 2010, in Berlin. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 53(5): 510–519. doi:10.1007/s00103-010-1074-3.CrossRefGoogle Scholar
  18. Littmann, J. 2010. Ethische Implikationen bei der Bekämpfung von Infektionskrankheiten – das Beispiel der Impfpriorisierung in Berlin während der H1N1-Pandemie. Berlin: Berlin School of Public Health.Google Scholar
  19. Löwer, J. 2010. Pandemieimpfstoffe: Überlegungen zum Design im Vorfeld der Influenzapandemie. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 53: 1238–1241. doi: DOI 10.1007/s00103-010-1159-z.CrossRefGoogle Scholar
  20. Malm, H., T. May, L.P. Francis, S.B. Omer, D.A. Salmon, and R. Hood. 2008. Ethics, pandemics, and the duty to treat. The American Journal of Bioethics: AJOB 8(8): 4–19. doi:10.1080/15265160802317974.CrossRefGoogle Scholar
  21. Marcic, A., J. Dreesman, B. Liebl, C. Schlaich, M. Suckau, W. Sydow, et al. 2010. H1N1 pandemic. Measures and experiences on the state level. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 53(12): 1257–1266. doi:10.1007/s00103-010-1164-2.CrossRefGoogle Scholar
  22. Martin, T. 2010. Pandemic as a communication challenge for the governmental authorities – an overview of the governmental public relations measures for the new influenza (“swine flu”). Basic communication features. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 53(12): 1304–1307. doi: 10.1007/s00103-010-1167-z.CrossRefGoogle Scholar
  23. McDougall, C.W. 2010. A survey of ethical principles and guidance within selected pandemic plans, 2nd ed. Montréal: National Collaborating Centre for Healthy Public Policy.Google Scholar
  24. Medlock, J., and P. Gavalli. 2009. Optimizing influenza vaccine distribution. Science 25: 1705–1708.CrossRefGoogle Scholar
  25. Montastruc, J.-L., G. Durrieu, and O. Rascol. 2011. Pandemrix°, (H1N1)v influenza and reported cases of narcolepsy. Vaccine 29(11): 2010–2010, doi:10.1016/j.vaccine.2010.12.092Google Scholar
  26. Nationaler Pandemieplan Teil I: Überblick über die Maßnahmen. 2007. Berlin: Robert-Koch-Institut.Google Scholar
  27. Parfit, D. 1997. Equality and priority. Ratio 10(3): 202–221.Google Scholar
  28. Robert-Koch Institut. 2009. Epidemiologisches Bulletin 41. Available at https://www.rki.de/DE/Content/Infekt/EpidBull/epid_bull_form.html.Google Scholar
  29. Robert-Koch Institut. 2010. Epidemiologisches Bulletin 31. Available at https://www.rki.de/DE/Content/Infekt/EpidBull/epid_bull_form.html.
  30. Schaade, L., A. Reuß, W. Haas, and G. Krause. 2010. Pandemieplanung. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 53(12): 1277–1282. doi:10.1007/s00103-010-1162-4.CrossRefGoogle Scholar
  31. Seitz, R., and G. Krause. 2010. Pandemien: Was haben wir aus der H1N1-Influenza gelernt? Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 53(12): 1221–1222. doi: 10.1007/s00103-010-1169-x.CrossRefGoogle Scholar
  32. Selgelid, M.J. 2009. Pandethics. Public health 123(3): 255–259. doi:10.1016/j.puhe.2008.12.005.CrossRefGoogle Scholar
  33. Straetemans, M., U. Buchholz, S. Reiter, W. Haas, and G. Krause. 2007. Prioritisation strategies for pandemic influenza vaccine in 27 countries of the EU and the global health security action group: A review. BMC Public Health 7(236).Google Scholar
  34. Transcript of Virtual Press Conference with Gregory Hartl Dr. Marie-Paule Kieny. 2009. Geneva: World Health Organization.Google Scholar
  35. Upshur, R., K. Faith, J. Gibson, A. Thompson, K. Wilson, and P.A. Singer. 2005. Stand on Guard for Thee: Ethical considerations in preparedness planning for pandemic influenza. Trans. J. C. f. Bioethics). Toronto: University of Toronto.Google Scholar
  36. Vaccination Guideline for Pandemic Influenza in Japan. 2007. ed. P. I. E. A. Committee. Japanese Ministry of Health, Labour and Welfare.Google Scholar
  37. van Delden, J.J., R. Ashcroft, A. Dawson, G. Marckmann, R. Upshur, and M.F. Verweij. 2008. The ethics of mandatory vaccination against influenza for health care workers. Vaccine 26(44): 5562–5566. doi:10.1016/j.vaccine.2008.08.002.CrossRefGoogle Scholar
  38. Vynnycky, E., and R.G. White. 2010. An introduction to infectious disease modelling. Oxford: OUP.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.Division of MedicineUniversity College LondonLondonUK

Personalised recommendations